> [!quote] Conclusion > This study demonstrated proof of concept that the [[RSS]] capsule can successfully collect a site-specific sample in the intestine. The study also suggests that samples from distinct locations in the GI tract can be different from fecal samples, and may offer unique insights into microbiome research. > > This device has potentially enormous implications for the microbiome field as a non-invasive, anatomical, site-specific collection method which may provide more insight on specific drug targets in the intestine. **Authors**: [[Pejman Rahimian|Pejman Rahimian PhD]], [[Shaoying Nikki Lee|Shaoying N. Lee PhD]], [[Nelson Quintana]], [[Chris Wahl|Chris Wahl MD]], [[Jeffrey Smith|Jeffery Smith, PhD]], [[Jacob Case]], and [[Sharat Singh|Sharat Singh PhD]] [Reference Poster](https://www.bioratherapeutics.com/wp-content/uploads/2022/05/Biora_DDW-Microbiome-Poster_May-2022_FINAL.pdf)